COVID-19 in children: the accumulated experience?
https://doi.org/10.21508/1027-4065-2020-65-5-193-197
Abstract
The article presents the main issues of COVID-19 in children, concerning the epidemiology, clinical course and risk groups. Despite the fact that COVID-19 affects children less often and it usually has a mild or asymptomatic course, there are severe and extremely severe courses especially in children and adolescents with certain risk factors (such as immunodeficiency, oncological diseases, obesity or other chronic diseases). The authors describe a clinical case of the severe course of COVID-19 in a 14-year-old teenager.
About the Authors
A. I. SafinaRussian Federation
I. I. Zakirov
Russian Federation
I. Ja. Lutfullin
Russian Federation
E. V. Volyanyuk
Russian Federation
M. A. Daminova
Russian Federation
References
1. Paules C.I., Eisinger R.W., Marston H.D., Fauci A.S. What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats. Ann Intern Med 2017; 167(11): 805-811.
2. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report — 51. World Health Organization, 11 Mar 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf
3. Bi Q., Wu Y., Mei S., Ye C., Zou X., Zhang Z. et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis 2020; 20(8): 911—919. DOI: 10.1016/S1473-3099(20)30287-5.
4. Sun K., Chen J., Viboud C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowd-sourced data: a population-level observational study. Lancet Digit Heal [Internet] 2020. https://linkinghub.elsevier.com/retrieve/pii/S2589750020300261
5. Wei M., Yuan J., Liu Y. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA 2020; 323(13): 1313—1314. DOI: 10.1001/jama.2020.2131
6. United States Centers for Disease Control and Prevention. Cases in the US. https://www.cdc.gov/coronavi-rus/2019-ncov/cases-updates/cases-in-us.html
7. Xia W, Jianbo S, Guo Y., Xia W., Shao J., Guo Y. et al. Clinical and CT features in pediatric patients with COVID 19 infection: Different points from adults. Pediatr Pulmonol 2020; 55(5): 1169—1174. DOI: 10.1002/ppul.24718
8. Cai J., Xu J., Lin D., Yang Z., Xu L., Qu Z. et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020; ciaa198. DOI: 10.1093/cid/ciaa198
9. Yu P., Zhu J., Zhang Z., Han Y.A. Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission. J Infect Dis 2020; 221(11): 1757—1761. DOI: 10.1093/infdis/jiaa077
10. Qiu H., Wu J., HongL., Luo Y., Song Q., Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20(6): 689—696. DOI: 10.1016/S1473-3099(20)30198-5
11. CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children — United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(14): 422—426. DOI: 10.15585/mmwr.mm6914e4
12. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J. et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020; 382(17): 1663—1665. DOI: 10.1056/NEJMc2005073
13. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics 2020; 145(6): e20200702. DOI: 10.1542/peds.2020-0702
14. Hu Z, Song C., Xu C., Jin G., Chen Y., Xu X. et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci 2020; 63(5): 706—711. DOI: 10.1007/s11427-020-1661-4
15. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382(18): 1708—1720. DOI: 10.1056/NEJMoa2002032
16. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 16—24 February 2020. World Health Organization 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
17. Yu H., Shao J., Guo Y. Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases. MedRixv [pre-print] 2020. DOI: 10.1101/2020.03.09.20032219
18. CDC COVID-19 Response Team. Preliminary Estimates ofthe Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12-March 28, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(13): 382—386. DOI: 10.15585/mmwr.mm6913e2
19. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34(5): e212—e213. DOI: 10.1111/jdv.16387
20. Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs B.J., Ross C.E., McKiernan C.A. et al. International COVID-19 PICU Collaborative. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr 2020. DOI: 10.1001/jamapediatrics.2020.1948
21. Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 6 (04.24.2020) (in Russ.). https://minzdrav.midural.ru/uploads
Review
For citations:
Safina A.I., Zakirov I.I., Lutfullin I.J., Volyanyuk E.V., Daminova M.A. COVID-19 in children: the accumulated experience? Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(5):193-197. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-5-193-197